Literature DB >> 2187191

Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

N K Bhat1, C B Thompson, T Lindsten, C H June, S Fujiwara, S Koizumi, R J Fisher, T S Papas.   

Abstract

The expression of the protooncogenes ETS1 and ETS2 has been studied in purified human T cells activated either by cross-linking of the T-cell receptor-CD3 complex on their cell surface or by direct stimulation with phorbol esters and ionomycin. Our results show that resting T cells express high levels of ETS1 mRNA and protein, while expression of ETS2 is undetectable. Upon T-cell activation, ETS2 mRNA and proteins are induced, while ETS1 gene expression decreases to very low levels. Late after stimulation, ETS1 mRNA is reinduced and maintained at a high level, while ETS2 gene expression decreases to undetectable levels. Therefore, it appears that in human T cells, ETS2 gene products are associated with cellular activation and proliferation, while ETS1 gene products are preferentially expressed in a quiescent state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187191      PMCID: PMC53975          DOI: 10.1073/pnas.87.10.3723

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The role of the T3/antigen receptor complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; B Manger; C Terhorst; J Stobo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

2.  Disappearance of statin, a protein marker for non-proliferating and senescent cells, following serum-stimulated cell cycle entry.

Authors:  E Wang; S L Lin
Journal:  Exp Cell Res       Date:  1986-11       Impact factor: 3.905

3.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

4.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.

Authors:  J C Reed; J D Alpers; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex.

Authors:  S Fujiwara; S Koizumi; R J Fisher; N K Bhat; T S Papas
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Interleukin-2 induction of T-cell G1 progression and c-myb expression.

Authors:  J B Stern; K A Smith
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

7.  Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans.

Authors:  D K Watson; M J McWilliams-Smith; C Kozak; R Reeves; J Gearhart; M F Nunn; W Nash; J R Fowle; P Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

Authors:  D K Watson; M J McWilliams-Smith; M F Nunn; P H Duesberg; S J O'Brien; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

Authors:  A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  52 in total

1.  Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition.

Authors:  D O Cowley; B J Graves
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

2.  Overexpression of ETS2 in human esophageal squamous cell carcinoma.

Authors:  Xin Li; Jia-Yun Lu; Li-Qun Zhao; Xiu-Qin Wang; Gui-Lin Liu; Zhong Liu; Chuan-Nong Zhou; Min Wu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  A positive regulator of the ribosomal protein gene, beta factor, belongs to the ETS oncoprotein family.

Authors:  T Yoganathan; N K Bhat; B H Sells
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

Review 4.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

6.  v-myb and v-ets cooperate for the mitogenic stimulation of primary fibroblasts by avian E26 retrovirus.

Authors:  P Ravel-Chapuis; D Leprince; B Pain; R Li; C Domenget; D Stehelin; J Samarut; P Jurdic
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques.

Authors:  L Robinson; A Panayiotakis; T S Papas; I Kola; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

8.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

9.  Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.

Authors:  H Dudek; R V Tantravahi; V N Rao; E S Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein.

Authors:  D B Woods; J Ghysdael; M J Owen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.